PCOS Treatment in Sherman, Texas, at DFWPMA

What Symptoms Can PCOS Treatment in Sherman Help With?

PCOS can produce a combination of menstrual, hormonal, dermatologic, and metabolic symptoms. Appropriate management may help patients address irregular cycles, excess androgen effects, insulin resistance, and other health concerns, with treatment decisions guided by individual symptoms and reproductive goals.

At DFWPMA Sherman, hormone and metabolic evaluations may be appropriate for patients experiencing:

• Unpredictable Menstrual Cycles: Periods that occur infrequently, irregularly, or not at all because ovulation is disrupted or absent.
• Increased Androgen Activity: Higher testosterone levels or other androgen-related abnormalities that may contribute to acne, excessive hair growth, or thinning scalp hair.
• Unwanted Facial or Body Hair: Hirsutism involving increased coarse hair growth on areas such as the chin, upper lip, chest, or abdomen.
• Recurring or Persistent Acne: Skin breakouts associated with androgen excess, especially when they occur alongside irregular menstruation or other PCOS symptoms.
• Thinning Hair on the Scalp: Female-pattern hair loss that may be influenced by androgen activity, although thyroid disease and other causes should also be considered.
• Reduced Insulin Sensitivity: Insulin resistance that may impair glucose regulation and contribute to increased risk of metabolic complications.
• Challenges Managing Body Weight: Difficulty reducing or maintaining weight when excess body fat contributes to metabolic concerns associated with PCOS.
• Elevated Glucose or Prediabetes: Blood sugar abnormalities that may increase the likelihood of progressing to Type 2 diabetes without appropriate monitoring and management.
• Ovulation-Related Fertility Difficulties: Trouble conceiving because ovulation occurs unpredictably, potentially requiring coordinated care with gynecology or a reproductive endocrinology specialist.
• Darkened Skin in Body Folds: Acanthosis nigricans, a skin change that may appear around the neck, underarms, or groin and can be associated with significant insulin resistance.
• Unfavorable Cholesterol Measurements: High triglycerides, reduced HDL cholesterol, or other lipid abnormalities that may contribute to cardiovascular risk.
• Extended Gaps Between Menstrual Periods: Prolonged absence of menstruation related to chronic anovulation, which may increase the risk of endometrial hyperplasia.

PCOS does not look the same in every patient. Some individuals experience prominent androgen-related symptoms, while others primarily have menstrual irregularities or metabolic concerns. Obesity, insulin resistance, and visibly polycystic ovaries are not present in every case.

In adults, a PCOS diagnosis generally requires at least two of three findings: androgen excess identified clinically or through testing, irregular or absent ovulation, or polycystic ovarian morphology. Other medical conditions capable of producing similar symptoms must first be excluded. For selected adult patients, anti-Müllerian hormone testing may be considered instead of ultrasound to assess polycystic ovarian morphology, but it cannot establish a PCOS diagnosis by itself.

Despite the name, PCOS does not require ovarian cysts to be identified. An adult with irregular menstrual cycles and confirmed androgen excess may meet diagnostic criteria without needing an ovarian ultrasound.

Metabolic health is an important consideration because PCOS is associated with higher rates of impaired glucose tolerance, Type 2 diabetes, abnormal cholesterol levels, and certain endometrial conditions. Appropriate screening helps identify these concerns even when menstrual or androgen-related symptoms are not severe.

PCOS can also interfere with conception by making ovulation less frequent or predictable. Patients planning a pregnancy may need a different management strategy from those primarily seeking menstrual cycle regulation or treatment of androgen-related symptoms.

Book a PCOS consultation in Sherman to discuss hormone testing, metabolic health, and individualized treatment recommendations.

What PCOS Treatments Are Available at DFWPMA Sherman?

PCOS-related endocrinology care at DFWPMA Sherman centers on evaluating hormonal abnormalities, assessing insulin resistance, and identifying medical risks that may require treatment. Dr. Gitana Staskus provides individualized endocrine assessments to help patients understand their symptoms and consider appropriate management options for associated metabolic and hormonal concerns.

Depending on symptoms, laboratory results, reproductive plans, and medical history, PCOS evaluations and treatment planning may include:

• Detailed PCOS Assessment: Review of menstrual patterns, androgen-related symptoms, changes in body weight, current medications, fertility goals, and associated health conditions.
• Targeted Hormone Blood Tests: Evaluation of testosterone and other relevant hormones when indicated to investigate androgen excess and rule out alternative endocrine causes.
• Diabetes and Glucose Regulation Screening: Assessment of blood sugar health, including consideration of a 75-gram oral glucose tolerance test, the most accurate recommended approach for evaluating glycemic status in PCOS.
• Insulin Resistance Care Planning: Individualized recommendations involving nutrition, physical activity, metabolic risk reduction, and medication when clinically appropriate.
• Metformin Eligibility Evaluation: Consideration of metformin for suitable adults with PCOS, particularly when improving metabolic outcomes and glucose regulation is a treatment priority.
• Menstrual Regulation Options: Discussion of hormonal contraceptives, progestogen-based approaches, or other suitable strategies for managing irregular menstrual cycles when medically appropriate.
• Management of Androgen-Related Symptoms: Evaluation of potential treatments for unwanted hair growth, acne, and scalp hair thinning, including hormonal or antiandrogen options when appropriate.
• Weight and Metabolic Health Strategies: Recommendations for managing weight-related concerns and consideration of anti-obesity medications when clinical eligibility criteria are met.
• Cardiovascular Risk Factor Monitoring: Assessment of blood pressure and cholesterol abnormalities, with coordination of medical treatment when necessary.
• Fertility-Related Care Coordination: Discussion of irregular ovulation and referral to gynecology or reproductive endocrinology when specialized fertility treatment is required.
• Endometrial Health Evaluation: Review of prolonged menstrual absence or abnormal uterine bleeding, with gynecologic assessment coordinated when indicated.
• Continued PCOS Follow-Up: Ongoing assessment of symptoms, glucose regulation, metabolic risk factors, medication response, and evolving treatment priorities.

There is no single therapy that addresses every aspect of polycystic ovary syndrome. Management should reflect whether the patient’s main concerns involve irregular menstrual periods, androgen-related symptoms, insulin resistance, body weight, or fertility.

Looking for PCOS treatment in Sherman, Texas? Contact DFWPMA to schedule an appointment or call (903) 957-0082 to discuss PCOS-related hormone evaluations and metabolic health management with Dr. Gitana Staskus.